The 2 analysts offering 12-month price forecasts for Harvard Bioscience Inc have a median target of 3.35, with a high estimate of 3.70 and a low estimate of 3.00. The median estimate represents a +9.84% increase from the last price of 3.05.
The current consensus among 2 polled investment analysts is to Buy stock in Harvard Bioscience Inc. This rating has held steady since November, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share $0.05
Reporting Date Mar 08
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.